[180 Pages Research Report] The global Cancer Immunotherapy Drug Discovery Outsourcing Market size was valued at USD 1.4 billion in 2023, and the market is projected to reach USD 2.9 billion by the end of 2030, with growth at a CAGR of 11.1% during the forecast report 2023-2030.
Outsourcing drug discovery for cancer immunotherapy refers to the process of using external service providers to complete numerous tasks for this type of research. What's important to know about this developing field is as follows:
The growing need for cancer treatment Due to its promise to offer more individualized and efficient therapies for cancer patients, cancer immunotherapy treatments are in increasing demand. Due to businesses' desire to hasten the development of novel and cutting-edge therapies, drug discovery for cancer immunotherapy treatments has increased in outsourcing.
Target identification, hit-to-lead optimization, lead optimization, preclinical development, and clinical trial management are a few examples of the processes associated with drug discovery that companies are outsourcing. Companies can now obtain specialized knowledge.
The emergence of contract research organizations (CROs): CROs are becoming more and more crucial in the outsourcing of cancer immunotherapy drug discovery. These businesses specialize in offering pharmaceutical and biotechnology companies research and development services, and they provide a variety of services, such as drug discovery, preclinical and clinical development, and regulatory affairs.
Location of outsourcing partners geographically: The location of outsourcing partners geographically can have a big impact on outsourcing drug discovery for cancer immunotherapy treatments. For instance, businesses might decide to outsource to areas with a robust infrastructure for research and development, a competent workforce, and hospitable regulatory regimes.
Collaboration is essential to the success of outsourcing drug discovery for cancer immunotherapy treatments. This includes collaboration between outsourcing partners and internal teams. To do this, effective, collaborative communication.
increased need for cancer immunotherapy: Due to the increased demand for cancer immunotherapy treatments, the market for outsourcing drug discovery in this industry is growing. The promise for these medicines to provide focused and effective treatments for cancer patients has led to an increase in investment in research and development activities.
Finding new drugs is getting harder and harder, requiring specific knowledge and resources. This category includes medications used in cancer immunotherapy. Through outsourcing, which also reduces costs and increases productivity, businesses can access these assets and competencies.
A growing number of contract research organizations (CROs) are emerging: The growth of CROs has a significant impact on the market for outsourcing drug discovery for cancer immunotherapy. Preclinical and clinical drug development are among the many services offered by CROs.
As per the report, the global Cancer Immunotherapy Drug Discovery Outsourcing Market is segmented into Type, Application, and Regions. The report covers detailed information on market size, Share, Growth, Value, Volume Analysis, Demand analysis, new market entry, competition insights, market drivers, challenges, opportunities, and Restraints. Further, company profile analysis, company revenue, Strategies, Sales, company acquisition, partnership, mergers, latest trends in the industry, regional and country-level insights, and competitive intelligence data is provided in the research report.
Further, the global market is geographically divided into major regions, and countries including North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Further, major countries focused in the global study report: United States, Canada, United Kingdom, Spain, Germany, Italy, France, Mexico, Russia, Ukraine, China, Japan, South Korea, India, Singapore, Malaysia, Australia, Qatar, Kingdom of Saudi Arabia, South Africa, Brazil, Argentina, and other countries are covered in the research study.
• Monoclonal Antibodies
• Immunomodulators
• Oncolytic Viral Therapies and Cancer Vaccines
• Others
• Target Identification and Validation
• Lead Screening and Characterization
• Cell-based Assays
• Lung
• Breast
• Colorectal
• Melanoma
• Prostate
• Head and Neck
• Ovarian
• Pancreatic
- North America
- Latin America
- Europe
- Middle East and Africa
- Asia Pacific
• North American market to remain in control over the global market during 2022-2030. In the North American region, the United States occupied the highest share of the market in this region, and the US country is projected to follow the same trend over the forecast time 2022-2030, followed by Canada.
• Europe holds the second largest share producer in the global Disposable Medical Sensors Market during the forecast period 2022-2030. Asia Pacific region is expected to be registered as the fastest-growing market in the global market by 2030.
• Most developing countries in Asia Pacific remain the focus of leading Disposable Medical Sensors companies, with a large portion of these companies investing in new entry and business expansion strategies
• The market in the Middle East and Africa is projected to show prominent growth opportunities in the coming years from 2023-2030. Due to the rising focus from the government of the Middle East and African countries on emerging healthcare infrastructure manufacturing and distribution are mostly contributing to the global market in the MEA region.
• The Latin American Disposable Medical Sensors Market registered a substantial share of the global market in 2022, and it is projected to remain its presence in the market.
• Covance Inc.
• Explicyte SAS
• Aquila BioMedical Ltd.
• Horizon Discovery Group PLC
• Crown Bioscience, Inc.
• Promega Corporation
• HD Biosciences Co., Ltd.
• BPS Bioscience, Inc.
• Genscript Biotech Corporation
• DiscoverX Corporation
• Celentyx Ltd.
*List not exhaustive
1. Executive Summary
1.1 Introduction to Cancer Immunotherapy Drug Discovery Outsourcing Markets
1.2 Cancer Immunotherapy Drug Discovery Outsourcing Market Size Outlook, 2021- 2030
1.3 Growth Opportunities in Cancer Immunotherapy Drug Discovery Outsourcing Industry
1.4 Winning Strategies for the post-pandemic future
2. Report Guide
2.1 Market Definition and Scope
2.2 Market Segmentation
2.3 Research Methodology
2.4 Forecast Methodology
2.5 List of Abbreviations
3. Growth Opportunity Analysis
3.1 Key Cancer Immunotherapy Drug Discovery Outsourcing Market Trends
3.2 Key Cancer Immunotherapy Drug Discovery Outsourcing Market Growth Drivers
3.3 Key Cancer Immunotherapy Drug Discovery Outsourcing Market Growth Restraints
4 Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook – Scenario Analysis
4.1 Low Growth Case Scenario Forecasts
4.2 Reference Growth Case Scenario Forecasts
4.3 High Growth Case Scenario Forecasts
5. Cancer Immunotherapy Drug Discovery Outsourcing Market Segmentation- Outlook by Drugs
5.1 Monoclonal Antibodies Market Outlook to 2030
5.2 Immunomodulators Market Outlook to 2030
5.3 Oncolytic Viral Therapies and Cancer Vaccines Market Outlook to 2030
5.4 Others Market Outlook to 2030
6. Cancer Immunotherapy Drug Discovery Outsourcing Market Segmentation- Outlook by Service
6.1 Target Identification and Validation Market Outlook to 2030
6.2 Lead Screening and Characterization Market Outlook to 2030
6.3 Cell-based Assays Market Outlook to 2030
7. Cancer Immunotherapy Drug Discovery Outsourcing Market Segmentation- Outlook by Therapeutic Area
7.1 Lung Market Outlook to 2030
7.2 Breast Market Outlook to 2030
7.3 Colorectal Market Outlook to 2030
7.4 Melanoma Market Outlook to 2030
7.5 Prostate Market Outlook to 2030
7.6 Head and Neck Market Outlook to 2030
7.7 Ovarian Market Outlook to 2030
7.8 Pancreatic Market Outlook to 2030
8. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook and Opportunities to 2030
8.1 Market Snapshot, 2023
8.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Growth Opportunities
8.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook by Application
8.4 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook by Type
8.5 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook by Country
8.6 United States Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
8.7 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
8.8 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
9. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook and Opportunities to 2030
9.1 Market Snapshot, 2023
9.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook by Application
9.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook by Type
9.4 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook by Country
9.5 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
9.6 France Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
9.7 United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
9.8 Spain Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
9.9 Italy Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
9.10 Other Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
10. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook and Opportunities to 2030
10.1 Market Snapshot, 2023
10.2 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook by Application
10.3 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook by Type
10.4 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook by Country
10.5 China Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
10.6 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
10.7 India Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
10.8 Other Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
11. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook and Opportunities to 2030
11.1 Market Snapshot, 2023
11.2 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook by Application
11.3 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook by Type
11.4 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook by Country
11.5 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
11.6 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
11.7 Other Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
12. Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook and Opportunities to 2030
12.1 Market Snapshot, 2023
12.2 Middle East and AfricaCancer Immunotherapy Drug Discovery Outsourcing Market Outlook by Application
12.3 Middle East and AfricaCancer Immunotherapy Drug Discovery Outsourcing Market Outlook by Type
12.4 Middle East and AfricaCancer Immunotherapy Drug Discovery Outsourcing Market Outlook by Country
12.5 Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
12.6 UAE Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
12.7 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
12.8 Other Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
13 Profiles of major Cancer Immunotherapy Drug Discovery Outsourcing Companies
Covance Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Explicyte SAS
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Aquila BioMedical Ltd.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Horizon Discovery Group PLC
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Crown Bioscience, Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Promega Corporation
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
HD Biosciences Co., Ltd.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
BPS Bioscience, Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Genscript Biotech Corporation
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
DiscoverX Corporation
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Celentyx Ltd.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
14. Appendix
14.1 Publisher’s Expertise
14.2 List of Tables and Charts
14.3 List of Exhibits
14.4 Legal Disclaimer
• Monoclonal Antibodies
• Immunomodulators
• Oncolytic Viral Therapies and Cancer Vaccines
• Others
• Target Identification and Validation
• Lead Screening and Characterization
• Cell-based Assays
• Lung
• Breast
• Colorectal
• Melanoma
• Prostate
• Head and Neck
• Ovarian
• Pancreatic